- Home
- OSUR vs TARA Comparison
OSUR vs TARA Comparison
Compare OSUR & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSUR | TARA |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.4M | 269.8M |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OSUR | TARA |
|---|---|---|
| Price | $4.18 | $3.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $3.00 | ★ $24.40 |
| AVG Volume (30 Days) | 801.7K | ★ 808.7K |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.25 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $167,064,000.00 | $2,948,000.00 |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $7.76 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.08 | $2.77 |
| 52 Week High | $4.33 | $7.82 |
Technical Indicators
Market Signals| Indicator | OSUR | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 63.86 | 35.70 |
| Support Level | $2.93 | $3.03 |
| Resistance Level | $4.33 | $5.53 |
| Average True Range (ATR) | 0.24 | 0.25 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 76.87 | 22.30 |
Price Performance
Historical ComparisonAbout OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.